We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Novozymes Biopharma to Present on Creating Market Opportunities Through Drug Half-Life Extension at 2011 BIO Business Forum

News   Jun 24, 2011

 
Novozymes Biopharma to Present on Creating Market Opportunities Through Drug Half-Life Extension at 2011 BIO Business Forum
 
 
Advertisement
 

RELATED ARTICLES

mRNA-1273 COVID-19 Vaccine Protects Airway in Nonhuman Primate Study

News

Two doses of an experimental vaccine to prevent coronavirus disease 2019 (COVID-19) induced robust immune responses and rapidly controlled the coronavirus in the upper and lower airways of rhesus macaques exposed to SARS-CoV-2.

READ MORE

“Love Hormone” Could Be Used to Treat Alzheimer’s

News

Scientists have suggested that oxytocin, also known as the “love hormone”, could be a potential new therapeutic option for cognitive disorders such as Alzheimer's disease.

READ MORE

Wuhan COVID-19 Vaccine Trials Show Early Positive Results, Moving Forward to Phase 3 Testing

News

The adenovirus type-5-vectored COVID-19 vaccine was shown to be safe and induced significant immune responses in the majority of recipients after a single immunization.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE